Procyon Technologies

Procyon Technologies is a bioresearch enterprise located in the United States. Its primary focus is on the Procyon cell encapsulation device, a small, flat, thin, highly durable, and flexible implantable chamber. It reduces foreign body reactions, promotes the formation of vascular structures on its surface, allows rapid diffusion of nutrients to the inner cells, and quickly absorbs insulin (or other therapeutic molecules) secreted by the encapsulated cells while providing a protective barrier against attacks from the human immune system without the need for immunosuppressive drugs. The design of Procyon Technologies is driven by practical clinical applications, including delivering oxygen to the implantable device, enabling tight packing of cells while maintaining their viability and functionality.